CCIR Distinguished Seminar Series
Invited Speakers for Fiscal Years 2012 and 2013
- November 10, 2011: "Frontiers in Therapeutic Manipulation of the Tumor Microenvironment: the Case of the PD1 Pathway" Drew Pardoll, M.D., Ph.D., Johns Hopkins University
- December 8, 2011: "Deconstructing Cancer Immunoediting" Robert Schreiber, Ph.D., Washington University
- January 5, 2012: "Generating and Maintaining Memory CD8 T Cells" John Harty, Ph.D., University of Iowa
- February 15, 2012: "Taking T Cell Therapies to Phase 3 and Licensure" Cliona Rooney, Ph.D., Baylor College of Medicine
- March 1, 2012: "Alternative Pathways for Memory CD8 T Cell Generation" Stephen Jameson, Ph.D., University of Minnesota
- April 5, 2012: "T Cell Traffic and Retention: Challenges and Opportunities for Immune Therapy of Melanoma" Craig Slingluff, M.D., University of Virginia
- May 3, 2012: "Targeting Foxp3+ Treg Cells to Promote Host Anti-tumor Immune Responses" Wayne Hancock, M.D., Ph.D., University of Pennsylvania
- June 7, 2012: "Roles of TRAFs in the Regulation of B-cell Function and Malignancy" Gail Bishop, Ph.D., University of Iowa
- October 31, 2012: "Origins of CD4+ Memory T Cells" Marc Jenkins, Ph.D., University of Minnesota Medical School
- November 14, 2012: "Exosomes: Mediators and Biomarkers of Disease" Douglas Taylor, Ph.D., University of Louisville
- December 6, 2012: "Innate and Adaptive Immunity Regulated within the Tumor Microenvironment" Thomas Gajewski, M.D., Ph.D., University of Chicago
- January 10, 2013: "Immunoregulation of Graft-versus-Host Disease" Bruce Blazer, M.D., University of Minnesota


